Utah's statute on stem cell therapy is a disclosure rule. It decides what you must be told and what you must sign. It does not decide whether a therapy is a good idea.
This is general information for anyone considering a clinic in Utah, ours or another. It is not legal or medical advice. It describes the statute as published in October 2026, and laws change, so the text itself is linked below.
What the statute is called, and where it sits
The law is Utah Code 58-1-512. Its title is three words: “Stem cell disclosure.” It sits in Title 58, “Occupations and Professions,” inside the Division of Professional Licensing Act, in the part on unlawful and unprofessional conduct. It was enacted in 2024 and took effect on May 1 of that year.
The address tells you what kind of law it is: a rule about how providers must conduct themselves, filed among the licensing rules. “Stem cell therapy” is the statute's own term, and this article uses it only as the statute does. The definition takes in afterbirth placental perinatal stem cells and the federal category of human cells, tissues, and cellular or tissue-based products.
Who may perform it, and on what condition
Utah law lets a health care provider whose scope of practice includes stem cell therapy perform a stem cell therapy that is not FDA-approved, but only after giving the patient a specific written notice and obtaining a signed consent form.
Utah's law is a state licensing rule about disclosure and consent. It does not make any therapy FDA-approved, and it does not change federal law.
Two conditions sit inside that first sentence. One is scope of practice. The section does not say which providers meet it, so it is a fair thing to ask: does your scope of practice include this? The other is the paperwork, which is the substance of the law.
The section also says who it does not apply to: a provider who holds an FDA investigational approval for the use of human cell and tissue products, and a provider who performs the therapy under an employment or other contract for an institution certified by one of the bodies the statute lists.
What the law does not do
The statute says a provider “may perform” a therapy, and it is easy to read more into those words than is there. Three limits are worth stating.
- It approves nothing. The statute does not say any therapy is safe, effective or approved, and it does not approve, license or certify any product or clinic.
- It leaves federal law where it was. The statute borrows a federal definition and refers to FDA approval status. It overrides nothing, and the federal rules for these products contain no exception for state law. See what “not FDA-approved” actually means.
- It sets no product standard. The text contains no rule on lab accreditation, donor testing, potency or quality. Where a product comes from and how it is handled are still your questions to ask.
The written notice
Before performing the therapy, the provider must give you a written notice. The statute is specific about its form: paper at least eight and a half by eleven inches, and type no smaller than forty point. The same notice must be prominently displayed at the entrance and in an area of the office visible to patients.
The wording is not left to the provider. The Legislature wrote it. Here it is in full, exactly as the statute sets it out.